{
  "ptid_time": "068_S_4061_2011-06-03",
  "img_path": "/data/qiuhui/data/adni/images/068_S_4061/2011-06-03/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 20,212 mm³, 9.5% below the reference mean. With a Z-score of -0.24 (40.6th percentile), this represents normal volume ; hippocampal volume measures 6,510 mm³, 15.3% below the reference mean. With a Z-score of -1.72 (4.3th percentile), this represents moderate atrophy; whole brain volume measures 1,009,500 mm³, 1.9% below the reference mean. With a Z-score of -0.24 (40.6th percentile), this represents normal volume ; entorhinal cortex volume measures 3,161 mm³, 18.8% below the reference mean. With a Z-score of -1.46 (7.3th percentile), this represents mild atrophy; fusiform gyrus volume measures 18,475 mm³, 1.5% above the reference mean. With a Z-score of 0.16 (56.5th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,938 mm³, 11.8% above the reference mean. With a Z-score of 1.05 (85.3th percentile), this represents mild enlargement. ",
  "text_data": "Age is 64.1 years. Gender is Female. Education: 16 years. Handedness: Left. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Major Surgical Procedures. MMSE: 29.0. MoCA: 26.0. Logical Memory: 8.0. Laboratory findings: Lymphocytes: 2.88 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.12 SUVR (normal ); Amyloid beta: 1369.00 pg/mL (normal ); Total tau: 188.10 pg/mL (normal ); Phosphorylated tau: 16.73 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal and entorhinal cortex volumes show moderate and mild atrophy, respectively, which are key regions affected in Alzheimer's disease. However, cognitive scores (MMSE 29, MoCA 26) are within normal limits, and biomarkers (Aβ, T-tau, P-tau, AV45) are normal, suggesting no current evidence of amyloid or tau pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (due to structural atrophy without significant cognitive decline or biomarker abnormalities).  \n\n**Confidence:** **Medium** (structural changes are concerning, but cognitive and biomarker data do not yet support dementia or clear neurodegenerative progression).",
  "timestamp": "2025-07-26T08:58:07.904504"
}